C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/48 (2006.01) A61K 31/506 (2006.01) A61P 25/00 (2006.01) C07D 239/50 (2006.01) C07D 401/02 (2006.01) C07D 401/04 (2006.01) C07D 401/06 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01) C07D 413/14 (2006.01) C07D 417/04 (2006.01) C07D 471/04 (2006.01) C07D 487/04 (2006.01)
Patent
CA 2676715
Compounds of formula (I) selectively inhibitproduction of A.beta.(1-42) and hence find use in treatment of Alzheimer's disease and other conditions associated with deposition ofA(.beta.) in the brain.
L'invention porte sur des composés de formule (I) qui inhibent de façon sélective la production de A.beta.(1-42) et trouvent par là utilisation dans le traitement de la maladie d'Alzheimer et autres conditions associées au dépôt de A(.beta.) dans le cerveau.
Blurton Peter
Fletcher Stephen
Hamblett Christopher
Harrison Timothy
Munoz Benito
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Piperazine derivatives for treatment of ad and related... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazine derivatives for treatment of ad and related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine derivatives for treatment of ad and related... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1783377